These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6187636)

  • 21. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
    Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present status of blood transfusion in Japan.
    Fujii H; Inoue N; Shimizu M
    Prog Clin Biol Res; 1990; 337():535-7. PubMed ID: 2353016
    [No Abstract]   [Full Text] [Related]  

  • 25. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Survey of blood donors on the topic of "reimbursement for blood donors"].
    Zeiler T; Kretschmer V
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):19-24. PubMed ID: 7727959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transfusion service in East Germany in 1984 (observations from a study tour)].
    Fiala J
    Vnitr Lek; 1985 Oct; 31(10):1020-5. PubMed ID: 4090292
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which methods of donor recruitment give the safest donors?
    Wylie B
    Malays J Pathol; 1993 Dec; 15(2):99-103. PubMed ID: 8065181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of hepatitis B virus deoxyribonucleic acid using real-time polymerase chain reaction method in pooled-plasma samples of Turkish blood donors.
    Karakoc AE; Berkem R; Beyaz E
    Clin Lab; 2009; 55(5-6):229-34. PubMed ID: 19728557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving health profile of blood donors as a consequence of transfusion safety efforts.
    Edgren G; Tran TN; Hjalgrim H; Rostgaard K; Shanwell A; Titlestad K; Wikman A; Norda R; Jersild C; Wideroff L; Gridley G; Adami J; Melbye M; Nyrén O; Reilly M
    Transfusion; 2007 Nov; 47(11):2017-24. PubMed ID: 17958530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
    Dunn P; Dinesh D
    N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The BSD Health Study: a pilot study to examine the comparability of Bavarian blood donors with the Bavarian general population by a comparison with KORA S4].
    Müller M; Ruf E; Weinauer F; Martin S; Becker C; Illig T; Döring A; Wichmann HE; Rapp S
    Gesundheitswesen; 2009 Aug; 71(8-9):481-8. PubMed ID: 19288426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Procedure for reduction of allotransfusion in operative medicine].
    Habler O
    HNO; 2003 Jan; 51(1):8-11. PubMed ID: 12557091
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-D sensitizations in the Leipzig District recorded in 1980 and 1981 and their relation to IgG-anti-D(Rh0) immunoprophylaxis].
    Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):133-45. PubMed ID: 6192048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voluntary donors-need for a second look.
    Kakkar N; Kaur R; Dhanoa J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):381-3. PubMed ID: 16295429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruitment of prospective donors: what do they expect from a homepage of a blood transfusion service?
    Moog R; Fourné K
    Transfus Med; 2007 Aug; 17(4):279-84. PubMed ID: 17680953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.